Search Results - "Maegawa, H."

Refine Results
  1. 1
  2. 2

    CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges by Edelmann, Mariola J., Maegawa, Gustavo H. B.

    Published in Frontiers in molecular biosciences (12-11-2020)
    “…During the past decades, several therapeutic approaches have been developed and made rapidly available for many patients afflicted with lysosomal storage…”
    Get full text
    Journal Article
  3. 3

    Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease by Maegawa, Gustavo H.B., Tropak, Michael B., Buttner, Justin D., Rigat, Brigitte A., Fuller, Maria, Pandit, Deepangi, Tang, Liangiie, Kornhaber, Gregory J., Hamuro, Yoshitomo, Clarke, Joe T.R., Mahuran, Don J.

    Published in The Journal of biological chemistry (28-08-2009)
    “…Gaucher disease (GD), the most prevalent lysosomal storage disease, is caused by a deficiency of glucocerebrosidase (GCase). The identification of small…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Clinical, biochemical, and genotype‐phenotype correlations of 118 patients with Niemann‐Pick disease Types A/B by Hu, Jiayue, Maegawa, Gustavo H.B., Zhan, Xia, Gao, Xiaolan, Wang, Yu, Xu, Feng, Qiu, Wenjuan, Han, Lianshu, Gu, Xuefan, Zhang, Huiwen

    Published in Human mutation (01-05-2021)
    “…Niemann‐Pick disease Types A and B (NPA/B) are autosomal recessive disorders caused by variants in the sphingomyelin phosphodiesterase‐1 (SMPD1) gene. This…”
    Get full text
    Journal Article
  6. 6

    Ambroxol improves skeletal and hematological manifestations on a child with Gaucher disease by Jiang, Wenjun, Yi, Mengni, Maegawa, Gustavo H B, Zhang, Huiwen

    Published in Journal of human genetics (01-03-2020)
    “…Gaucher disease (GD) is a lysosomal storage disease caused by the deficiency of glucocerebrosidase characterized by a broad spectrum of clinical manifestations…”
    Get full text
    Journal Article
  7. 7

    Chronic kidney disease categories and renal–cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25) by Yokoyama, H., Araki, S., Haneda, M., Matsushima, M., Kawai, K., Hirao, K., Oishi, M., Sugimoto, K., Sone, H., Maegawa, H., Kashiwagi, A.

    Published in Diabetologia (01-07-2012)
    “…Aims/hypothesis In type 2 diabetic patients at low risk for cardiovascular disease (CVD), the relationship between the clinical course of nephropathy by stage…”
    Get full text
    Journal Article
  8. 8

    USP8 inhibition regulates autophagy flux and controls Salmonella infection by Santelices, John, Ou, Mark, Maegawa, Gustavo H B, Hercik, Kamil, Edelmann, Mariola J

    “…Ubiquitination is an important protein modification that regulates various essential cellular processes, including the functions of innate immune cells…”
    Get full text
    Journal Article
  9. 9

    A diagnosis of non‐neuronopathic and late‐onset acid sphingomyelinase deficiency (Niemann‐Pick disease A/B) following bone marrow biopsy showing foamy histiocytosis by SahBandar, Ivo N., Maegawa, Gustavo H. B., Brandman, Danielle, Rand, Jacob H., Lim, Hana I., Geyer, Julia T.

    Published in EJHaem (01-10-2024)
    “…SEE PDF] The clinical history and bone marrow biopsy findings were suspicious for lysosomal storage disease, and subsequent sphingomyelinase enzymatic activity…”
    Get full text
    Journal Article
  10. 10

    The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported by Maegawa, Gustavo H. B, Stockley, Tracy, Tropak, Michael, Banwell, Brenda, Blaser, Susan, Kok, Fernando, Giugliani, Roberto, Mahuran, Don, Clarke, Joe T.R

    Published in Pediatrics (Evanston) (01-11-2006)
    “…Juvenile GM2 gangliosidosis is a group of inherited neurodegenerative diseases caused by deficiency of lysosomal beta-hexosaminidase resulting in GM2…”
    Get full text
    Journal Article
  11. 11

    Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study by Kadowaki, T, Sekikawa, A, Murata, K, Maegawa, H, Takamiya, T, Okamura, T, El-Saed, A, Miyamatsu, N, Edmundowicz, D, Kita, Y

    Published in International Journal of Obesity (01-07-2006)
    “…Visceral adipose tissue (VAT) is an independent risk factor for metabolic and cardiovascular disorders. There has been no study that demonstrated different…”
    Get full text
    Journal Article
  12. 12

    Use of Ambroxol as Therapy for Gaucher Disease by Zhan, Xia, Zhang, Huiwen, Maegawa, Gustavo H B, Wang, Yu, Gao, Xiaolan, Wang, Dengbin, Li, Jinning

    Published in JAMA network open (01-06-2023)
    “…Ambroxol was identified as an enhancer of stability and residual activity of several misfolded glucocerebrosidase variants in 2009. To assess hematologic and…”
    Get full text
    Journal Article
  13. 13

    Pyrimethamine as a Potential Pharmacological Chaperone for Late-onset Forms of GM2 Gangliosidosis by Maegawa, Gustavo H.B., Tropak, Michael, Buttner, Justin, Stockley, Tracy, Kok, Fernando, Clarke, Joe T.R., Mahuran, Don J.

    Published in The Journal of biological chemistry (23-03-2007)
    “…Late-onset GM2 gangliosidosis is composed of two related, autosomal recessive, neurodegenerative diseases, both resulting from deficiency of lysosomal,…”
    Get full text
    Journal Article
  14. 14

    Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM) by Tobe, K., Maegawa, H., Nakamura, I., Uno, S.

    Published in Sakharnyĭ diabet (14-07-2021)
    “…STELLA-LONG TERM, a 3-year post-marketing surveillance study, evaluated the safety and effectiveness of the sodiumglucose cotransporter 2 inhibitor…”
    Get full text
    Journal Article
  15. 15

    Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1 by Han, Shiqian, Zhang, Huiwen, Yi, Mengni, Liu, Xiaoqing, Maegawa, Gustavo H. B., Zou, Yunding, Wang, Qijun, Wu, Dianqing, Ye, Zhijia

    Published in Frontiers in pharmacology (09-06-2021)
    “…Background: Niemann-Pick disease type C1 (NP-C1) is a rare, autosomal-recessive neurodegenerative disorder with no United States Food and Drug Administration…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Isofagomine Induced Stabilization of Glucocerebrosidase by Kornhaber, Gregory J, Tropak, Michael B, Maegawa, Gustavo H, Tuske, Steven J, Coales, Stephen J, Mahuran, Don J, Hamuro, Yoshitomo

    “…Structurally destabilizing mutations in acid β-glucosidase (GCase) can result in Gaucher disease (GD). The iminosugar isofagomine (IFG), a competitive…”
    Get full text
    Journal Article
  18. 18

    Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36) by Yokoyama, H, Araki, S, Kawai, K, Hirao, K, Oishi, M, Sugimoto, K, Sone, H, Maegawa, H, Kashiwagi, A

    Published in Diabetes research and clinical practice (01-09-2015)
    “…Abstract Aims The protective association of pioglitazone with cardiovascular events and death was investigated over 6-years in large-scale type 2 diabetic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Genetic variants at CDC123/CAMK1D and SPRY2 are associated with susceptibility to type 2 diabetes in the Japanese population by Imamura, M., Iwata, M., Maegawa, H., Watada, H., Hirose, H., Tanaka, Y., Tobe, K., Kaku, K., Kashiwagi, A., Kawamori, R., Nakamura, Y., Maeda, S.

    Published in Diabetologia (01-12-2011)
    “…Aims/hypothesis Recently, rs10906115 in CDC123/CAMK1D , rs1359790 near SPRY2 , rs1436955 in C2CD4A/C2CD4B and rs10751301 in ODZ4 were identified as genetic…”
    Get full text
    Journal Article